iBio, Inc. Common Stock (IBIO) stock news · rev $100.0K
iBio, Inc. Common Stock (IBIO) is a biotechnology company listed on US.
This IBIO news page leads with what iBio, Inc. Common Stock filed — not a scraped headline mill.
No cached 8-K sentence for IBIO yet. We will not pad this page with generic market recap.
Latest reported IBIO revenue for 2026-06-30 was $100.0K. Net income was -$32.8M. Revenue was down 75.0% from 2025-06-30 to 2026-06-30. IBIO currently screens at market cap $13.4M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the IBIO stock page; for the tape open the quote page.
IBIO cached headlines
Newest cached · 2026-09-01T20:30:00.000Z
- iBio to Participate in the 2026 Wells Fargo Annual Healthcare Conference — Yahoo Finance
- iBio Reports Fiscal Year 2026 Financial Results and Provides Corporate Update — Yahoo Finance
- iBio Strengthens Clinical Leadership with Appointment of Endocrinologist Molly Carr as Chief Medical Officer — Yahoo Finance
- iBio Reports Single Dose of IBIO-610 Achieved Near-Complete Active Activin E Inhibition Through Eight Weeks in Obese NHP Study — Yahoo Finance
- Could iBio (IBIO) Be an Underrated Obesity Stock? — Yahoo Finance
- iBio to Participate in Upcoming Healthcare Investor Conferences — Yahoo Finance
+9 older cached headlines in the full archive.
These headlines as JSON? API free 100/dayIBIO stock news FAQ
What is IBIO's latest news headline?
The latest cached iBio, Inc. Common Stock (IBIO) headline on this page is "iBio to Participate in the 2026 Wells Fargo Annual Healthcare Conference" from Yahoo Finance on Sep 1, 2026. Story: https://lician.com/news/ibio/724. News: https://lician.com/news/ibio
When was the latest cached IBIO headline published?
The latest cached iBio, Inc. Common Stock (IBIO) headline on this page was published Sep 1, 2026. The earliest headline date on this page is Mar 16, 2026.
How many IBIO headlines are listed on this page?
This page lists 15 cached iBio, Inc. Common Stock (IBIO) headlines. News: https://lician.com/news/ibio
What other IBIO headlines are listed on this page?
Other cached headlines on this iBio, Inc. Common Stock (IBIO) news page: "iBio Reports Fiscal Year 2026 Financial Results and Provides Corporate Update"; "iBio Strengthens Clinical Leadership with Appointment of Endocrinologist Molly Carr as Chief Medical Officer"; "iBio Reports Single Dose of IBIO-610 Achieved Near-Complete Active Activin E Inhibition Through Eight Weeks in Obese NHP Study". News: https://lician.com/news/ibio
What source is listed on the IBIO news page?
The cached source on this iBio, Inc. Common Stock (IBIO) news page is Yahoo Finance. News: https://lician.com/news/ibio
What does the latest IBIO headline say?
The latest cached iBio, Inc. Common Stock (IBIO) headline is "iBio to Participate in the 2026 Wells Fargo Annual Healthcare Conference". SAN DIEGO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ: IBIO), a clinical-stage biotechnology company developing long-acting antibody therapeutics for obesity, cardiometabolic and cardiopulmonary diseases, today announced that it will participate in the Wells Fargo 21st Annual Healthcare Conference, taking place September 8-10, 2026, in Boston. Martin Brenner, DVM, Ph.D., Chief Executive Officer and Chief….
What are IBIO's latest revenue and net income?
Latest cached iBio, Inc. Common Stock (IBIO) revenue for Jun 30, 2026 was $100.0K. Net income was -$32.8M. Statements: https://lician.com/financials/ibio
Where is IBIO stock news listed?
Cached stock news for iBio, Inc. Common Stock (IBIO) is listed at https://lician.com/news/ibio. Filings: https://lician.com/sec/ibio
Not investment advice.